Crossover Study to Assess the Relative Bioavailability and Bioequivalence of Niraparib Tablet Compared to Niraparib Capsule
Clinical trial NCT03329001 · COMPLETED
Trial details
- NCT number
- NCT03329001
- Sponsor
- Tesaro, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-04
- Primary completion
- 2021-12-30
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.